Literature DB >> 18715650

Disseminated salmonellosis in a patient treated with temozolomide.

Georgiana Georgescu1, Ignatio M Isola, Souad Youssef, Javier Adachi, Kenneth Rolston.   

Abstract

Temozolomide is a relatively new chemotherapeutic agent frequently associated with selective CD4+ T-lymphocytopenia. Patients with cell-mediated immune defects are at higher risk for acquiring infections with Salmonella species. We describe the first case of disseminated salmonellosis in a patient treated with temozolomide.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18715650     DOI: 10.1016/j.jinf.2008.06.021

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  4 in total

1.  Tonsillar pseudotumor: complications of chronically-administered temozolomide.

Authors:  Kathleen Grisdale; Melesa Ritterhouse; Kathy Hunter; Michelle D Williams; Morris D Groves
Journal:  J Neurooncol       Date:  2010-05-04       Impact factor: 4.130

2.  Cerebral aspergillosis within new tumour site presents as incidental new brain lesion in patient receiving temozolomide for glioblastoma multiforme.

Authors:  Shiyuan Anabeth Liu; Timothy Sullivan; Clare Bryce; Amy M Chan; Salvatore Cilmi
Journal:  BMJ Case Rep       Date:  2019-05-31

3.  Should CD4 Levels be Monitored in a Patient on Temozolomide?

Authors:  Sriram Gonakoti; Luis Parra-Rodriguez
Journal:  Eur J Case Rep Intern Med       Date:  2021-03-11

4.  Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma.

Authors:  Gil Redelman-Sidi; Christian Grommes; Genovefa Papanicolaou
Journal:  J Neurooncol       Date:  2010-07-30       Impact factor: 4.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.